Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01287377 · ClinicalTrials.gov registry record · Phase 3
Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging
A Phase 3 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 3
- Development phase
- 243
- Enrollment target
NCT01287377: Completed Phase 3 study, sponsored by University of California, San Diego.
NCT01287377 is a Phase 3 study that has completed, run by University of California, San Diego. The registered enrollment target is 243 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01287377, a Phase 3 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 243 participants
- Enrollment target
Study Summary
The primary purpose of this study is to test the feasibility of sending pre-cessation nicotine patches and to examine the effects associated with the pre-cessation treatment phase. Specifically, this study aims to: 1. See if subjects will use pre-cessation nicotine patches. 2. See if subjects in the pre-cessation nicotine patches go on to get more nicotine patches. 3. See if pre-cessation treatment with nicotine patches leads to a decrease in number of cigarettes smoked per day. 4. See if sending 2-weeks' worth of patches is helpful to the quitting process.
Primary Outcome
At a given point in time (in this case, 2 months after program registration), quitline participants are asked whether they have used cigarettes or other forms of tobacco in the past 30 days. Those who reply that they have not used tobacco in the past 30 days are considered to have quit.
Interventions
- DRUG Nicotine Patches
- BEHAVIORAL Telephone Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-11 |
| Phase | Phase 3 |
What the finished NCT01287377 record still lists
NCT01287377 is an interventional study that assigns participants to a tested intervention. The registered 243 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Nicotine Patches is the first listed.
NCT01287377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01287377 about?
NCT01287377 is a clinical study titled "Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging". The primary purpose of this study is to test the feasibility of sending pre-cessation nicotine patches and to examine the effects associated with the pre-cessation treatment phase. Specifically, this study aims to: 1. See if subjects will use pre-cessation nicotine patches. 2. See if subjects in th...
What is the current status of trial NCT01287377?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 243 participants. The study started on 2010-11. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01287377?
The interventions under investigation include: Nicotine Patches (DRUG), Telephone Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01287377?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01287377's enrollment target sits among peer trials
243 1269th of 2000 higher than 731 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06253871 · 243 participants · Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NCT06289491 · 243 participants · NA
A Trial of Hydrus Microstent Versus Goniotomy
- NCT06536296 · 243 participants · NA
The Impact of Music Medicine on Preterm Brain Development and Behavior
- NCT06907615 · 243 participants · Phase 2
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia